French Biomarker Company TcLand Names Huriez Chairman and CEO

September 27, 2006
BioPharm International Editors

TcLand S.A. (Nantes, France, www.tcland-biotech.com) has named Alain Huriez, MD, one of the company's co-founders, as Chairman and CEO.

TcLand S.A. (Nantes, France, www.tcland-biotech.com) has named Alain Huriez, MD, one of the company’s co-founders, as Chairman and CEO. Past roles held by Huriez include vice president of Quintiles Europe (in charge of the firm’s biotechnology consulting group) and CEO of Neovacs SA. TcLand developed diagnostic biomarkers and therapeutic molecules for patients with immune disorders, and runs immunological tests for biopharmaceutical companies conducting clinical trials.

Related Content:

News